Literature DB >> 9743171

Acute Q fever pneumonia: a review of 80 hospitalized patients.

F Caron1, J C Meurice, P Ingrand, A Bourgoin, P Masson, P Roblot, F Patte.   

Abstract

STUDY
OBJECTIVES: To emphasize epidemiologic, clinical, or radiologic characteristics whose detection could lead to an early diagnosis and to enhance therapeutic efficacy. PATIENTS: Eighty hospitalized patients from 1982 to 1996.
DESIGN: The diagnosis of Q fever infection was serologically confirmed in all the patients (phase II Coxiella burnetii antibody) using the complement fixation test and/or the indirect immunofluorescence antibody test.
RESULTS: Patients from rural and urban areas were noted in the same proportion; however, the usual epidemiologic factors such as contact with cats or farm animals were found in 40% of the patients. Mean age+/-SD was 49+/-20 years, and there was a higher sex ratio of male to female patients (1:3.44). We found a specific seasonal distribution since 80% of the cases occurred between February and May. Delay before referring to hospital was 8.2+/-7.8 days, while 69.3% of the patients received an antibiotic treatment that was mainly penicillin or cephalosporin. The dominant clinical features were dry cough and high fever, as the maximal temperature reached more then 40 degrees C in 58% of the patients. Digestive symptoms were rare. WBC count remained within normal range in 80% of the cases with a low proportion of lymphocytes in half of the patients, and the sedimentation rate was usually elevated (55+/-34 mm). Altered liver function consisted more frequently in an elevated level of alkaline phosphatase (70% of the cases) than transaminases, while hyponatremia was frequently mentioned (28.2% of the patients). We found radiologic evidence of unique lobar or segmental alveolar opacity involving more likely the lower lobes in 55 patients, and multiple or interstitial opacities in the others. Chest radiographs were considered normal in eight patients. The clinical response was favorable in all the patients with a reduction in fever 4.8+/-3.9 days after the start of treatment with the second antibiotic that included mainly erythromycin or quinolones, and chest radiographs returned to normal in 81% of the patients within the first month.

Entities:  

Mesh:

Year:  1998        PMID: 9743171     DOI: 10.1378/chest.114.3.808

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Q fever seroprevalence and associated risk factors among students from the Veterinary School of Zaragoza, Spain.

Authors:  M C Valencia; C O Rodriguez; O G Puñet; I de Blas Giral
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

3.  High-Content Screening, a Reliable System for Coxiella burnetii Isolation from Clinical Samples.

Authors:  Rania Francis; Maxime Mioulane; Marion Le Bideau; Marie-Charlotte Mati; Pierre-Edouard Fournier; Didier Raoult; Jacques Yaacoub Bou Khalil; Bernard La Scola
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

4.  Newer macrolides as empiric treatment for acute Q fever infection.

Authors:  A Gikas; D P Kofteridis; A Manios; J Pediaditis; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Acute Q fever pneumonia: high-resolution computed tomographic findings in six patients.

Authors:  Felipe Mussi von Ranke; Fernanda Miraldi Clemente Pessoa; Felipe Batista Afonso; Josiani Bastos Gomes; Danielle Provençano Borghi; Alessandro Severo Alves de Melo; Edson Marchiori
Journal:  Br J Radiol       Date:  2019-01-04       Impact factor: 3.039

6.  Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands.

Authors:  Cornelia C H Wielders; Annemarie M H Wuister; Veerle L de Visser; Monique G de Jager-Leclercq; Cornelis A R Groot; Frederika Dijkstra; Arianne B van Gageldonk-Lafeber; Jeroen P G van Leuken; Peter C Wever; Wim van der Hoek; Peter M Schneeberger
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

7.  Two cases of q-Fever in hairy cell leukemia.

Authors:  Emanuele Ammatuna; Emilio Iannitto; Lidwine W Tick; Nicolaas L A Arents; Philip H Kuijper; Marten R Nijziel
Journal:  Case Rep Hematol       Date:  2014-08-12

8.  Airborne geographical dispersal of Q fever from livestock holdings to human communities: a systematic review and critical appraisal of evidence.

Authors:  Nicholas J Clark; Ricardo J Soares Magalhães
Journal:  BMC Infect Dis       Date:  2018-05-15       Impact factor: 3.090

9.  Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.

Authors:  Jung Min Cho; Jisuk Chae; Sa Rang Jeong; Min Jung Moon; Dong Yeob Shin; Jong Ho Lee
Journal:  PLoS One       Date:  2020-10-19       Impact factor: 3.240

10.  Cat or dog ownership and seroprevalence of ehrlichiosis, Q fever, and cat-scratch disease.

Authors:  Martina Skerget; Christoph Wenisch; Florian Daxboeck; Robert Krause; Renate Haberl; Doris Stuenzner
Journal:  Emerg Infect Dis       Date:  2003-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.